|
Commercialization Pathways - Licensing Research Reagents
1. Licensing Cre-lox Transgenic Mice
If you have used the CRE-lox mouse system, click here for a summary of the intellectual property issues that apply to CRE-lox
2. The National Cancer Institute has developed a comprehensive website on mouse models of human cancer. Mouse models recapitulate many aspects of the genesis, progression, and clinical course of human cancers and are valuable resources to cancer researchers engaged in a variety of basic, translational, clinical, and epidemiological investigations. The NCI Mouse Models of Human Cancers Consortium (MMHCC) is a collaborative program designed to derive and characterize mouse models, and to generate resources, information, and innovative approaches to the application of mouse models in cancer research.
|
